share_log

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

Merck & Co | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

默沙東 | 11-K:員工持股年度報告
美股sec公告 ·  06/26 01:40
牛牛AI助理已提取核心訊息
Merck & Co., Inc. has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the Merck US Savings Plan, an employee stock purchase, savings, and similar plan. The independent audit conducted by PricewaterhouseCoopers LLP concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets available for benefits for the year in conformity with U.S. generally accepted accounting principles. The Plan's net assets available for benefits increased from $11.528 billion at the end of 2022 to $13.424 billion at the end of 2023. The Plan is designed to provide employees with a means of...Show More
Merck & Co., Inc. has filed its Form 11-K annual report for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The report details the financial performance of the Merck US Savings Plan, an employee stock purchase, savings, and similar plan. The independent audit conducted by PricewaterhouseCoopers LLP concluded that the financial statements present fairly the net assets available for benefits as of December 31, 2023, and the changes in net assets available for benefits for the year in conformity with U.S. generally accepted accounting principles. The Plan's net assets available for benefits increased from $11.528 billion at the end of 2022 to $13.424 billion at the end of 2023. The Plan is designed to provide employees with a means of saving and investing for the future, with options to invest in various funds, including Merck common stock. The Plan is subject to the Employee Retirement Income Security Act of 1974 (ERISA) and is administered by committees appointed by Merck's CEO and Board of Directors. Contributions to the Plan can be made by employees up to certain limits, with matching contributions from Merck. The Plan's investments are held in a Master Trust along with other Merck plans, and the financial statements include a detailed breakdown of the Plan's assets and liabilities, contributions, and investment income.
默沙東公司已向美國證券交易所提交了其於2023年12月31日結束的財政年度的Form 11-K年度報告。該報告詳細介紹了默沙東美國儲蓄計劃的財務表現,該計劃是員工股票購買、儲蓄以及類似計劃。普華永道會計師事務所進行的獨立審計結論認爲,財務報表按照美國普遍會計原則,合理地呈現了2023年12月31日可用於福利的淨資產以及該年度可用於福利的淨資產變化情況。計劃的可用於福利的淨資產從2022年底的1152.8億美元增加到2023年底的1342.4億美元。該計劃旨在爲員工提供儲蓄和未來投資的手段,包括投資於各種基金,包括默沙東普通股。該計劃受1974年《僱員退休保障法》(ERISA)約束,由默沙東公司CEO和董事會任命的委員會管理。員工可以按照一定的限制向該計劃進行貢獻,並得到默沙東公司的匹配投資。計劃的投資與其他默沙東計劃一起在主信託中進行,財務報表包括計劃資產和負債、貢獻和投資收益的詳細分項。
默沙東公司已向美國證券交易所提交了其於2023年12月31日結束的財政年度的Form 11-K年度報告。該報告詳細介紹了默沙東美國儲蓄計劃的財務表現,該計劃是員工股票購買、儲蓄以及類似計劃。普華永道會計師事務所進行的獨立審計結論認爲,財務報表按照美國普遍會計原則,合理地呈現了2023年12月31日可用於福利的淨資產以及該年度可用於福利的淨資產變化情況。計劃的可用於福利的淨資產從2022年底的1152.8億美元增加到2023年底的1342.4億美元。該計劃旨在爲員工提供儲蓄和未來投資的手段,包括投資於各種基金,包括默沙東普通股。該計劃受1974年《僱員退休保障法》(ERISA)約束,由默沙東公司CEO和董事會任命的委員會管理。員工可以按照一定的限制向該計劃進行貢獻,並得到默沙東公司的匹配投資。計劃的投資與其他默沙東計劃一起在主信託中進行,財務報表包括計劃資產和負債、貢獻和投資收益的詳細分項。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。